QC
COYA icon

Quadrature Capital’s Coya Therapeutics COYA Stock Holding History

Quadrature Capital’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$180K Buy
+30,783
New +$143K ﹤0.01% 1379
2025
Q4 		– Sell
-19,894
Closed -$114K – 1321
2025
Q3 		$114K Buy
+19,894
New +$121K ﹤0.01% 862

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Quadrature Capital's COYA Position: Q2 2026 in Review

Quadrature Capital opened a new position in Coya Therapeutics (COYA) in Q2 2026: 30,783 shares worth $180K. The stake represents ﹤0.01% of the portfolio and ranks #1379 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in COYA as recently as Q3 2025.

Quadrature Capital first reported a position in COYA in Q3 2025 and has held it in 2 quarters since. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • Quadrature Capital held 30,783 shares of Coya Therapeutics worth $180K as of Q2 2026.
  • Coya Therapeutics was a new Quadrature Capital position in Q2 2026.
  • Coya Therapeutics made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1379 holding.
  • Quadrature Capital first reported a position in Coya Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.